7 results match your criteria: "Clinical Specialist Lead[Affiliation]"
Br J Nurs
January 2025
Clinical Specialist Lead, NHS Supply Chain, Vascular Access Specialist Practitioner (Honorary), Frimley Health NHS Foundation Trust, and Board Member/Treasurer, NIVAS.
Br J Nurs
July 2024
Clinical Specialist Lead, NHS Supply Chain, Vascular Access Specialist (Hon) Practitioner, Frimley Health NHS Foundation Trust and NIVAS Treasurer/Board Member.
Br J Nurs
July 2023
Clinical Specialist Lead, NHS Supply Chain, Vascular Access Specialist Practitioner (Honorary), Frimley Health NHS Foundation Trust, and Board Member/Treasurer, NIVAS.
Br J Nurs
October 2022
NIVAS Board Member/Treasurer, Clinical Specialist Lead, NHS Supply Chain, and Honorary Specialist Practitioner, Frimley Health NHS Foundation Trust.
Br J Nurs
July 2022
Clinical Specialist Lead, NHS Supply Chain, Vascular Access Specialist Practitioner (Honorary), Frimley Health NHS Foundation Trust and board member/treasurer, NIVAS.
Br J Cardiol
March 2021
Programme Lead for Postgraduate Cardiorespiratory Physiotherapy Education University College London Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 3EH.
The incremental shuttle walk test (ISWT) is a valid, reliable submaximal exercise test used in the assessment of patients prior to cardiac rehabilitation (CR). Simultaneous electrocardiogram (ECG) measurements would provide important information on the safety of the test, and adequacy of subsequent cardiac risk stratification. Risk stratification is recommended to assess patients' suitability for cardiac rehabilitation.
View Article and Find Full Text PDFBr J Nurs
January 2019
Clinical Nurse Specialist for Vascular Access and Intravenous Therapy-affiliated with Frimley Health NHS Foundation Trust, seconded as Clinical Specialist Lead NHS Clinical Evaluation Team/Department of Health and Social Care; Visiting Lecturer, University of Surrey, and Clinical Specialist Lead - Clinical Collaboration Team/NHS Supply Chain.
Studies have demonstrated that up to 90% of all inpatients require the insertion of some form of an intravenous (IV) access device to facilitate therapy administration, which has also become as an essential aide in diagnostics and monitoring. These devices, particularly peripheral IV cannulas (PIVCs) are not without risks and complications. The NHS is trying to improve the safety and quality of health care by implementing evidence-based practices and one way to reduce the risks of PIVC-related complications is by to choose devices that are fit for purpose.
View Article and Find Full Text PDF